Binod Dhakal, MD, MS, discusses some of the next steps for evaluating ciltacabtagene autoleucel in multiple myeloma and the CARTITUDE-4 trial.

Alx Oncology Holdings, Inc. ( (ALXO) ) has released its Q3 earnings. Here is a breakdown of the information Alx Oncology Holdings, Inc.

Renowned Indian folk singer Sharda Sinha has passed away due to cancer. She had been on a ventilator since November 4, and ...

More than one in five people across the United States is likely to suffer from long COVID-19, a new AI-generated review has ...

Adaptive Biotechnologies get expanded medicare coverage of clonoSEQ for assessing measurable residual disease in mantle cell lymphoma: Seattle Saturday, November 9, 2024, 15:00 Hr ...

Gil Blum, an analyst from Needham, maintained the Buy rating on Autolus Therapeutics (AUTL – Research Report). The associated price ...

The company’s lead ddCAR product candidate is anitocabtagene autoleucel, which is in phase 2 clinical trial for the treatment ...

Scalise announced last year he was diagnosed with a blood cancer known as multiple myeloma, though he said the treatments he ...

Arcellx (NASDAQ:ACLX – Free Report) had its target price raised by HC Wainwright from $80.00 to $95.00 in a research report released on Wednesday,Benzinga reports. The firm currently has a buy rating ...

SpringWorks to present long-term efficacy and safety data from phase 3 DeFi trial of Ogsiveo in adults with desmoid tumours at CTOS 2024 meeting ...

‘A TOADY’: Lau, a Chinese political advisory body member, sparked controversy with his song “Chinese People” and the concert was said to be part of China’s “united front” tactics Employment ...

Even single day's delay in deciding bail plea adversely affects fundamental rights of citizens: SC NEW DELHI: Deprecating the practice of courts keeping bail applications pending for years, the ...